Abstract: The invention relates to in vitro or ex vivo methods for assessing the cognitive function of a subject in the context of the prevention of neurodegenerative diseases. A particular method comprises a step of associating a subject to a cognitive status selected from healthy cognitive status, Subjective Cognitive Impairment, Mild Cognitive Impairment and neurodegenerative disease, and the association of cognitive status results from the evaluation of glycosylated MCSF and CCR2 expressed at the surface of PBMC in a biological sample from the subject. The present invention also provides kits suitable for implementing such methods.
Type:
Grant
Filed:
February 26, 2016
Date of Patent:
January 7, 2020
Assignee:
ADventDX
Inventors:
Nicolas Pelletier, Philippe Compagnone, Nathalie Compagnone